PAX2 and nonpapillary renal cell carcinoma: Finally, diffuse protein expression of Pax-2 has been reported to be frequent in three of the most prevalent RCT subtypes - ccRCC, pRCC and oncocytoma - but not in chrRCC, suggesting its use for differential diagnosis in problematic cases [17, 19, 23, 28].